Acknowledgement for APICES collaboration in DART 01/05 study published in “The Lancet Oncology” Once more time we are privileged to share the acknowledgment that APICES has received in the recent publication titled: “High-dose radiotherapy and risk-adapted androgen deprivation in localized prostate cancer (DART 01/05): 10-year results of a phase 3 randomised, controlled trial”. This is…
Acknowledgement for APICES collaboration in INMUNOSUN study published in “ESMO Open” We are privileged to share the acknowledgment that APICES has received in the recent publication titled: “Results from the INMUNOSUN-SOGUG trial: a prospective phase II study of sunitinib as a second-line therapy in patients with metastatic renal cell carcinoma after immune checkpoint-based combination therapy”,…
Acknowledgement for APICES collaboration in FDO-LMA-2016-01 study published in “Medicine International” This month, we want to share the acknowledgment that APICES has received in the recent publication titled “Biomarker-driven phase IB clinical trial of OPB-111077 in acute myeloid leukemia”, published in Medicine International in which APICES has collaborated in several tasks of the project as design, setup, coordination…
Acknowledgement for APICES collaboration in NACASY study published in “Cancers” Once more time we are privileged to share the acknowledgment that APICES has received in the recent publication titled: “A Prospective, Real-Word, Multinational Study of Naloxegol for Patients with Cancer Pain Diagnosed with Opioid-Induced Constipation-The NACASY Study”, a study in which APICES has participated in…
Acknowledgement for APICES collaboration in VERNE study published in “Digestive and Live Disease” We are privileged to share the acknowledgment that APICES has received in the recent publication titled: “Treatment patterns and intensification within 5 year of follow-up of the first-line anti-TNFα used for the treatment of IBD: Results from the VERNE study”, a study…
Acknowledgment for APICES collaboration in TIME study published in “Expert Opinion on Pharmacotherapy” We are privileged to share the acknowledgment that APICES has received in the recent publication titled: “Impact on functionality of the paliperidone palmitate three-month formulation in patients with a recent diagnosis of schizophrenia: a real-world observational prospective study”, published in Expert Opinion…
Acknowledgment for APICES collaboration in PROBIOTIC trial published in Pharmaceuticals From APICES, we are privileged to share the acknowledgment that we have received in the recent publication titled: “Efficacy and Tolerability of the Probiotic VSL#3 for the Treatment of Patients with Fibromyalgia and Associated Gastrointestinal Symptomatology; A Randomized Double-blind Clinical trial” published in Pharmaceuticals related with one…
Acknowledgment for APICES collaboration in a GICOR trial published in Radiotherapy and Oncology From APICES, we are privileged to share the acknowledgment that we have received in the recent publication titled “Prognostic value of testosterone castration levels following androgen deprivation and high-dose radiotherapy in localized prostate cancer: Results from a phase III trial” published in…
GESTO platform: Publication of results of observational studies with medicinal products for human use After approval of the RD 957/2020 which regulates observational studies with medicinal products for human use it is mandatory the publication of results of observational studies with medicinal products for human use in the spanish clinical trials registry, as we mentioned…
NEW DATA PROTECTION CODE OF CONDUCT BY EUCROF Procedure and technical measures in order to comply with General Data Protection Regulation 2016/679 are being more and more standardized through codes of conduct in several fields. Until now, there are not a code of conduct geared to Contract Research Organization (CRO). EUCROF has been working in…
